Subscribe To Our Free Newsletter |
Auro Pharma’s Andhra Pradesh facility gets 3 USFDA observations
The pharmaceutical company announced that the US drug regulator has concluded its inspection at the new injectable facility in Andhra Pradesh, with three observations.